Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Jon C. Ogg | Oct 28, 2013 at 11:25 AM EDT

Four Companies That Easily Could Run the Healthcare.gov Sign-Up Process

Healthcare.govSince the passage of the Affordable Care Act, or Obamacare, the launch has been riddled with problems. Accessing the sign-up…

Paul Ausick | Oct 28, 2013 at 7:50 AM EDT

Merck Continues to Face Revenue Challenges

ThinkstockDrug giant Merck & Co. Inc. (NYSE: MRK) reported third-quarter 2013 results before markets opened Monday morning. The company posted…

Jon C. Ogg | Oct 21, 2013 at 12:10 PM EDT

eHealth Wins as Obamacare Technology Flop Persists

ThinkstockIt is not uncommon that a loss of business at one provider is a win for other providers. If you…

Jon C. Ogg | Oct 18, 2013 at 9:30 AM EDT

pSivida, Alimera and Ariad Join Bio-Implosion Watch

ThinkstockBiotech and emerging health care technology companies both fit into a high-stake poker match on Wall Street. Investors can earn…

Paul Ausick | Oct 17, 2013 at 10:25 AM EDT

UnitedHealth Earnings OK, Outlook Disappoints

ThinkstockUnitedHealth Group Inc. (NYSE: UNH) reported third-quarter 2013 results before markets opened Thursday morning. The health insurance and benefits management…

Jon C. Ogg | Oct 17, 2013 at 9:45 AM EDT

Amarin Implosion: The Future Went from Promising to Doubtful

ThinkstockBiotech is a sector where investors know they are entering a high-stakes game of big risk and big reward. That…

Douglas A. McIntyre | Oct 17, 2013 at 6:44 AM EDT

Oreos Are as Addictive as Cocaine

ThinkstockSome good news for makers of cookies and candy. Recent research shows that Oreos are as addictive as cocaine. However, the companies…

Paul Ausick | Oct 15, 2013 at 8:35 AM EDT

Johnson & Johnson Growth Stalls

Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) reported third-quarter 2013 results before markets opened Tuesday morning. The health care giant posted…

Jon C. Ogg | Oct 14, 2013 at 2:36 PM EDT

Is Inhalable Insulin Assured To Be Approved By The FDA?

ThinkstockIf you have followed the diabetes drug market for very long, chances are high that you have run across the…

Jon C. Ogg | Oct 14, 2013 at 12:00 PM EDT

Coronado Implodes over Crohn’s Failure, Future Now Uncertain

Investing in biotech and emerging pharmaceutical stocks comes with a huge risk and reward profile for investors. Some wins are…

Trey Thoelcke | Oct 14, 2013 at 8:15 AM EDT

Jefferies Top Biotech Stocks to Buy

ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…

Paul Ausick | Oct 10, 2013 at 7:30 AM EDT

The Economic Impact of Obamacare: What’s Missing

Thinkstock What’s Missing — October 21, 2013 The implementation of the health insurance exchanges that began on October 1 has…

Jon C. Ogg | Oct 9, 2013 at 9:45 AM EDT

FDA Hold on Ariad Kills $2 Billion in Value (Updated)

via Wikimedia CommonsAriad Pharmaceuticals Inc. (NASDAQ: ARIA) is getting crushed on Wednesday due to a clinical hold placed by the…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

Jon C. Ogg | Oct 8, 2013 at 2:47 PM EDT

Market Take: Biotech Suffers Under Government Shutdown Too!

ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such,…

1 … 298 299 300 301 302 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Four Companies That Easily Could Run the Healthcare.gov Sign-Up Process

Merck Continues to Face Revenue Challenges

eHealth Wins as Obamacare Technology Flop Persists

pSivida, Alimera and Ariad Join Bio-Implosion Watch

UnitedHealth Earnings OK, Outlook Disappoints

Amarin Implosion: The Future Went from Promising to Doubtful

Oreos Are as Addictive as Cocaine

Johnson & Johnson Growth Stalls

Is Inhalable Insulin Assured To Be Approved By The FDA?

Coronado Implodes over Crohn’s Failure, Future Now Uncertain

Jefferies Top Biotech Stocks to Buy

The Economic Impact of Obamacare: What’s Missing

FDA Hold on Ariad Kills $2 Billion in Value (Updated)

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Market Take: Biotech Suffers Under Government Shutdown Too!

Meta vs. Alphabet: Which Stock Deserves a Spot in Your Portfolio After Q2?

Forget VFIAX: Vanguard Sells You the Same S&P 500 Fund Without the $3,000 Toll, or the $75 Fee Fidelity Charges to Buy It

Nvidia and Micron Have Driven the S&P 500’s 2026 Rally to Record Highs. History Says It’s Not Over

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

Social Security Said He Owed $18,000. Before Draining His Savings, He Had Three Cards to Play.

Meta vs. Alphabet: Which Stock Deserves a Spot in Your Portfolio After Q2?

Forget VFIAX: Vanguard Sells You the Same S&P 500 Fund Without the $3,000 Toll, or the $75 Fee Fidelity Charges to Buy It

Health and Healthcare Articles

All Health and Healthcare Articles

Four Companies That Easily Could Run the Healthcare.gov Sign-Up Process

Merck Continues to Face Revenue Challenges

eHealth Wins as Obamacare Technology Flop Persists

pSivida, Alimera and Ariad Join Bio-Implosion Watch

UnitedHealth Earnings OK, Outlook Disappoints

Amarin Implosion: The Future Went from Promising to Doubtful

Oreos Are as Addictive as Cocaine

Johnson & Johnson Growth Stalls

Is Inhalable Insulin Assured To Be Approved By The FDA?

Coronado Implodes over Crohn’s Failure, Future Now Uncertain

Jefferies Top Biotech Stocks to Buy

The Economic Impact of Obamacare: What’s Missing

FDA Hold on Ariad Kills $2 Billion in Value (Updated)

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Market Take: Biotech Suffers Under Government Shutdown Too!

Meta vs. Alphabet: Which Stock Deserves a Spot in Your Portfolio After Q2?

Forget VFIAX: Vanguard Sells You the Same S&P 500 Fund Without the $3,000 Toll, or the $75 Fee Fidelity Charges to Buy It

Nvidia and Micron Have Driven the S&P 500’s 2026 Rally to Record Highs. History Says It’s Not Over

Featured Reads

A Retired Couple Can Pull About $47,500 From Their IRAs This Year and Pay $0 Federal Tax. Most Leave the Free Space Unused.

Social Security Said He Owed $18,000. Before Draining His Savings, He Had Three Cards to Play.